272BIO

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

272BIO

Gent ·KBO/BCE: BE 0762.638.249

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility Decision tools Company map

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Developers Badge Business information compared Free company information

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Your question travels, with the dossier's public data, to our AI model at Anthropic in the US. Nothing that identifies you goes along, and we keep neither question nor answer. Answers can be wrong, so this is not legal advice. How it works

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	12-01-2026	19 d early	2026-00005902
30-06-2024	31-01-2025	30-01-2025	1 d early	2025-00024879
30-06-2023	31-01-2024	31-01-2024	on the day	2024-00025485
30-06-2022	31-01-2023	06-02-2023	6 d late	2023-00024712

Fiscal year	2025
Deposit	verkort
Revenue	-
EBITDA	€-531k
Net profit	€-632k
Cash flow	€-556k
Staff costs	€590k
Income taxes	€2k
Dividends	-
Total assets	€710k
Equity	€-225k
Debt	€935k
of which ≤ 1y	€856k
of which > 1y	-
Working capital	€-427k
Employees (FTE)	5.2

	2025
Current ratio	0.50
Quick ratio	0.50
Working capital ratio	-60.1%
Solvency	-31.8%
Debt / equity	-4.15
Long-term debt ratio	-
Interest coverage	-19.63
Gross margin	-
Net margin	-
ROA	-89.0%
ROE	280.3%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€710k
Fixed assets	21/28	€280k
Tangible fixed assets	22/27	€262k
Financial fixed assets	28	€19k
Current assets	29/58	€429k
Amounts receivable within one year	40/41	€62k
Cash & bank	54/58	€351k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€710k
Equity	10/15	€-225k
Contributions / capital	10/11	€1.21M
Accumulated profits (losses)	14	€-1.44M
Amounts payable	17/49	€935k
Amounts payable within one year	42/48	€856k
Trade debts payable within one year	44	€156k
Income statement
Gross operating margin	9900	€104k
Operating result	9901	€-606k
Financial income	75	€3k
Financial charges	65	€27k
Result before taxes	9903	€-630k
Income taxes	67/77	€2k
Net result for the period	9904	€-632k
Result to be appropriated	9905	€-632k

NACE primary	Vervaardiging van geneesmiddelen(21201)
Legal form	Private limited company(610)
Incorporation	28-01-2021
Status	Active
Postal code	9052

Summary

Conclusion

Bankruptcy probability (12 mo)

Signals

Filing behaviour

Trust signals

Administrative Flags

Financials

Annual accounts & ratios

Health barometer

Directors

Directors & mandates

Insolvency mandates

Legal Structure

Structure & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Publications

Lifecycle & Insolvency Signals

Belgisch Staatsblad · acts

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)